The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other cardiometabolic diseases. Surging medical costs and regulatory changes hit ...

US Stock market futures are facing pressure as tariff uncertainty continues to dominate the conversation. The S&P 500, Dow ...

Biodesix Inc (BDSX) reports impressive revenue growth but faces hurdles in sales team expansion and revised guidance.